Overview
Pancytopenia-developmental delay syndrome is an extremely rare genetic condition that affects both the blood system and brain development. The name describes its two main features: pancytopenia, which means low levels of all three types of blood cells (red blood cells, white blood cells, and platelets), and developmental delay, which means children reach milestones like sitting, walking, and talking later than expected. Because all blood cell types are reduced, affected individuals may experience anemia (causing tiredness and pale skin), increased risk of infections (due to low white blood cells), and easy bruising or bleeding (due to low platelets). The developmental delays can range from mild to more significant and may include intellectual disability. Some children may also have physical features or other organ involvement depending on the specific genetic cause. This syndrome is classified under constitutional aplastic anemias (ICD-10 code D61.0), meaning the bone marrow does not produce enough blood cells from early in life. Treatment is mainly supportive, focusing on managing low blood counts through transfusions, infection prevention, and developmental therapies. In some cases, bone marrow transplantation may be considered. Because this condition is so rare, management is highly individualized and typically coordinated by a team of specialists.
Key symptoms:
Low red blood cell count causing tiredness and pale skinLow white blood cell count leading to frequent infectionsLow platelet count causing easy bruising and bleedingDelayed milestones such as sitting, walking, or talkingIntellectual disabilityPoor growth or short statureFatigue and low energyRecurrent fevers from infectionsUnusual bleeding such as nosebleeds or bleeding gumsLearning difficulties
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Pancytopenia-developmental delay syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pancytopenia-developmental delay syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Pancytopenia-developmental delay syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pancytopenia-developmental delay syndrome.
Community
No community posts yet. Be the first to share your experience with Pancytopenia-developmental delay syndrome.
Start the conversation →Latest news about Pancytopenia-developmental delay syndrome
No recent news articles for Pancytopenia-developmental delay syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my child's pancytopenia, and how often will blood counts need to be checked?,Is bone marrow transplantation an option for my child, and what are the risks and benefits?,What genetic testing has been done, and are there any specific genes identified?,What signs of infection or bleeding should prompt an emergency room visit?,What developmental therapies should my child be receiving, and how often?,Are there any clinical trials or research studies my child might be eligible for?,What is the expected long-term outlook for my child's blood counts and development?
Common questions about Pancytopenia-developmental delay syndrome
What is Pancytopenia-developmental delay syndrome?
Pancytopenia-developmental delay syndrome is an extremely rare genetic condition that affects both the blood system and brain development. The name describes its two main features: pancytopenia, which means low levels of all three types of blood cells (red blood cells, white blood cells, and platelets), and developmental delay, which means children reach milestones like sitting, walking, and talking later than expected. Because all blood cell types are reduced, affected individuals may experience anemia (causing tiredness and pale skin), increased risk of infections (due to low white blood ce
How is Pancytopenia-developmental delay syndrome inherited?
Pancytopenia-developmental delay syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pancytopenia-developmental delay syndrome typically begin?
Typical onset of Pancytopenia-developmental delay syndrome is infantile. Age of onset can vary across affected individuals.